查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1285863

外泌體技術市場（外泌體類型：裝載的貨物[肽、siRNA、mRNA、miRNA、蛋白質、化學品和其他]和非貨物） - 2023-2031年全球行業分析、規模、佔有率、成長、趨勢和預測

Exosome Technologies Market (Exosome Type: Loaded Cargos [Peptide, siRNA, mRNA, miRNA, Protein, Chemical, and Others] and Non-cargo) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 208 Pages | 商品交期: 2-10個工作天內

價格

外顯子技術市場- 報告的範圍

TMR關於全球外顯子技術市場的報告研究了過去以及當前的成長趨勢和機會，以獲得對2023年至2031年預測期間市場指標的寶貴見解。報告提供了2017-2031年期間全球外顯子技術市場的收入，考慮到2023年為基準年，2031年為預測年。報告還提供了2023年至2031年全球外顯子技術市場的複合年成長率（CAGR %）。

該報告是在廣泛的研究後編寫的。一級研究涉及大部分的研究工作，其中分析師與關鍵意見領袖、行業領袖和意見製造者進行了訪談。二級研究包括參考主要參與者的產品資料、年度報告、新聞稿和相關文件，以了解等離子體材料市場。

該報告深入研究了全球等離子體材料市場的競爭格局。在全球外顯子技術市場運作的主要參與者已被確定，其中每一個都在各種屬性方面進行了分析。公司概況、財務狀況、最近的發展和SWOT是本報告中介紹的全球外顯子技術市場參與者的屬性。

目錄

第一章：前言

  • 市場定義和範圍
  • 市場細分
  • 主要研究目標
  • 研究重點

第二章：假設和研究方法

第三章：執行摘要：全球市場

第四章：市場概述

  • 簡介
    • 外泌體類型的定義
    • 行業演變/發展
  • 概述
  • 市場動態
    • 驅動力
    • 限制因素
    • 機會
  • 2017-2031年全球市場分析與預測
    • 市場收入預測
    • 市場容量/單位出貨量預測

第五章：關鍵洞察力

  • 管線分析
  • 技術進步
  • COVID-19大流行對行業的影響（價值鍊和短期/中期/長期的影響）

第六章：全球市場分析和預測：按外顯子類型分類

  • 介紹和定義
  • 主要研究結果/發展情況
  • 2017-2031年按外顯子類型的市場價值預測
    • 裝載的卡古斯
      • 肽
      • siRNA
      • mRNA
      • miRNA
      • 蛋白質
      • 化學製品
      • 其他
    • 非貨物
  • 按外泌體類型分類的市場吸引力

第7章：全球市場分析和預測：按細胞來源分類

  • 介紹和定義
  • 主要發現/發展
  • 2017-2031年按細胞來源的市場價值預測
    • HEK293 細胞
    • 間充質幹細胞
    • 血小板
    • 紅血球細胞
    • 自然殺傷細胞
    • 其他細胞
  • 不同細胞來源的市場吸引力

第八章：全球市場分析與預測：按應用分類

  • 介紹和定義
  • 主要發現/發展
  • 2017-2031年按應用的市場價值預測
    • 治療學
      • 腫瘤學
      • 神經退行性疾病
      • 心血管疾病
      • 傳染性疾病
      • 化妝品
    • 診斷學
  • 按應用分類的市場吸引力

第九章：全球市場分析與預測：按終端用戶分類

  • 介紹和定義
  • 主要發現/發展
  • 2017-2031年按終端用戶的市場價值預測
    • 醫療保健供應商
    • 製藥和生物技術公司
    • 其他
  • 各終端用戶的市場吸引力

第十章：全球市場分析和預測：按地區分類

  • 主要發現
  • 按地區的市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 國家/地區的市場吸引力

第十一章：北美洲市場分析與預測

  • 簡介
    • 主要發現
  • 2017-2031年按外顯子類型的市場價值預測
    • 負載型外泌體
      • 肽類
      • siRNA
      • mRNA
      • miRNA
      • 蛋白質
      • 化學製品
      • 其他
    • 非貨物
  • 2017-2031年按細胞來源的市場價值預測
    • HEK293細胞
    • 間充質幹細胞
    • 血小板
    • 紅血球細胞
    • 自然殺傷細胞
    • 其他
  • 2017-2031年按應用的市場價值預測
    • 治療學
      • 腫瘤學
      • 神經退行性疾病
      • 心血管疾病
      • 傳染性疾病
      • 化妝品
    • 診斷學
  • 2017-2031年按終端用戶的市場價值預測
    • 醫療保健供應商
    • 製藥和生物技術公司
    • 其他
  • 按國家分類的市場價值預測，2017 - 2031年
    • 美國
    • 加拿大
  • 市場吸引力分析
    • 按外泌體類型
    • 按細胞來源分類
    • 按應用分類
    • 按終端用戶分類
    • 按國家分類

第十二章：歐洲市場分析和預測

  • 簡介
    • 主要發現
  • 2017-2031年按外顯子類型的市場價值預測
    • 負載型外泌體
      • 肽類
      • siRNA
      • mRNA
      • miRNA
      • 蛋白質
      • 化學製品
      • 其他
    • 非貨物
  • 2017-2031年按細胞來源的市場價值預測
    • HEK293細胞
    • 間充質幹細胞
    • 血小板
    • 紅血球細胞
    • 自然殺傷細胞
    • 其他
  • 2017-2031年按應用的市場價值預測
    • 治療學
      • 腫瘤學
      • 神經退行性疾病
      • 心血管疾病
      • 傳染性疾病
      • 化妝品
    • 診斷學
  • 2017-2031年按終端用戶的市場價值預測
    • 醫療保健供應商
    • 製藥和生物技術公司
    • 其他
  • 按國家分類的市場價值預測，2017 - 2031年
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 市場吸引力分析
    • 按外泌體類型
    • 按細胞來源分類
    • 按應用分類
    • 按終端用戶
    • 按國家分類

第13章：亞太地區市場分析和預測

  • 簡介
    • 主要發現
  • 2017-2031年按外裝體類型的市場價值預測
    • 負載型外泌體
      • 肽類
      • siRNA
      • mRNA
      • miRNA
      • 蛋白質
      • 化學製品
      • 其他
    • 非貨物
  • 2017-2031年按細胞來源的市場價值預測
    • HEK293細胞
    • 間充質幹細胞
    • 血小板
    • 紅血球細胞
    • 自然殺傷細胞
    • 其他
  • 2017-2031年按應用的市場價值預測
    • 治療學
      • 腫瘤學
      • 神經退行性疾病
      • 心血管疾病
      • 傳染性疾病
      • 化妝品
    • 診斷學
  • 2017-2031年按終端用戶的市場價值預測
    • 醫療保健供應商
    • 製藥和生物技術公司
    • 其他
  • 按國家分類的市場價值預測，2017 - 2031年
    • 中國
    • 日本
    • 印度
    • 澳大利亞和新西蘭
    • 亞太其他地區
  • 市場吸引力分析
    • 按外泌體類型
    • 按細胞來源分類
    • 按應用分類
    • 按終端用戶
    • 按國家分類

第十四章：拉美市場分析和預測

  • 簡介
    • 主要發現
  • 2017-2031年按外源體類型的市場價值預測
    • 負載型外泌體
      • 肽類
      • siRNA
      • mRNA
      • miRNA
      • 蛋白質
      • 化學製品
      • 其他
    • 非貨物
  • 2017-2031年按細胞來源的市場價值預測
    • HEK293細胞
    • 間充質幹細胞
    • 血小板
    • 紅血球細胞
    • 自然殺傷細胞
    • 其他
  • 2017-2031年按應用的市場價值預測
    • 治療學
      • 腫瘤學
      • 神經退行性疾病
      • 心血管疾病
      • 傳染性疾病
      • 化妝品
    • 診斷學
  • 2017-2031年按終端用戶的市場價值預測
    • 醫療保健供應商
    • 製藥和生物技術公司
    • 其他
  • 按國家分類的市場價值預測，2017 - 2031年
    • 巴西
    • 墨西哥
    • 拉美其他地區
  • 市場吸引力分析
    • 按外泌體類型
    • 按細胞來源分類
    • 按應用分類
    • 按終端用戶
    • 按國家分類

第15章：中東和非洲市場分析和預測

  • 簡介
    • 主要發現
  • 2017-2031年按外源體類型的市場價值預測
    • 裝載的卡哥
      • 肽類
      • siRNA
      • mRNA
      • miRNA
      • 蛋白質
      • 化學製品
      • 其他
    • 非貨物
  • 2017-2031年按細胞來源的市場價值預測
    • HEK293細胞
    • 間充質幹細胞
    • 血小板
    • 紅血球細胞
    • 自然殺傷細胞
    • 其他
  • 2017-2031年按應用的市場價值預測
    • 治療學
      • 腫瘤學
      • 神經退行性疾病
      • 心血管疾病
      • 傳染性疾病
      • 化妝品
    • 診斷學
  • 2017-2031年按終端用戶的市場價值預測
    • 醫療保健供應商
    • 製藥和生物技術公司
    • 其他
  • 按國家分類的市場價值預測，2017 - 2031年
    • 海灣合作委員會國家
    • 南非
    • 中東和非洲其他地區
  • 市場吸引力分析
    • 按外泌體類型
    • 按細胞來源分類
    • 按應用分類
    • 按終端用戶
    • 按國家分類

第16章：競爭格局

  • 市場參與者- 競爭矩陣（按公司的層級和規模）。
  • 按公司分類的市場佔有率分析（2021年）
  • 公司簡介
    • AEGLE Therapeutics
    • Aruna Bio, Inc.
    • Bio-Techne Corporation (Exosome Diagnostics, Inc.)
    • Carmine Therapeutics, Inc.
    • Codiak BioSciences, Inc.
    • Creative Biolabs
    • Danaher Corporation (Beckman Coulter, Inc.)
    • Fujifilm Holdings Corporation
    • NOVADIP Biosciences SA
    • OmniSpirant Limited
    • Thermo Fisher Scientific, Inc.
Product Code: TMRGL65840

Exosome Technologies Market - Scope of Report

TMR's report on the global Exosome Technologies Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Exosome Technologies Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Exosome Technologies Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Exosome Technologies market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Exosome Technologies market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Exosome Technologies market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Exosome Technologies market.

The report delves into the competitive landscape of the global Exosome Technologies market. Key players operating in the global Exosome Technologies Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Exosome Technologies Market profiled in this report.

Key Questions Answered in Global Exosome Technologies Market Report:

  • What is the sales/revenue generated by Exosome Technologies across all regions during the forecast period?
  • What are the opportunities in the global Exosome Technologies market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Exosome Technologies Market - Research Objectives and Research Approach

The comprehensive report on the global Exosome Technologies Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Exosome Technologies Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Exosome Technologies market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Exosome Technologies Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Exosome Type Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Exosome Technologies Market Analysis and Forecasts, 2017 - 2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
    • 4.4.2. Market Volume/Unit Shipments Projections

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Technological Advancements
  • 5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Exosome Technologies Market Analysis and Forecasts, by Exosome Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Exosome Type, 2017 - 2031
    • 6.3.1. Loaded Cargos
      • 6.3.1.1. Peptide
      • 6.3.1.2. siRNA
      • 6.3.1.3. mRNA
      • 6.3.1.4. miRNA
      • 6.3.1.5. Protein
      • 6.3.1.6. Chemical
      • 6.3.1.7. Others
    • 6.3.2. Non-cargo
  • 6.4. Market Attractiveness By Exosome Type

7. Global Exosome Technologies Market Analysis and Forecasts, by Cell Source

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Cell Source, 2017 - 2031
    • 7.3.1. HEK293 Cells
    • 7.3.2. MSCs
    • 7.3.3. Platelets
    • 7.3.4. Erythrocytes
    • 7.3.5. Natural Killer Cells
    • 7.3.6. Others
  • 7.4. Market Attractiveness By Cell Source

8. Global Exosome Technologies Market Analysis and Forecasts, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Application, 2017 - 2031
    • 8.3.1. Therapeutics
      • 8.3.1.1. Oncology
      • 8.3.1.2. Neurodegenerative Diseases
      • 8.3.1.3. Cardiovascular Diseases
      • 8.3.1.4. Infectious Diseases
      • 8.3.1.5. Cosmetics
    • 8.3.2. Diagnostics
  • 8.4. Market Attractiveness By Application

9. Global Exosome Technologies Market Analysis and Forecasts, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2017 - 2031
    • 9.3.1. Health Care Providers
    • 9.3.2. Pharmaceutical & Biotechnology Companies
    • 9.3.3. Others
  • 9.4. Market Attractiveness By End-user

10. Global Exosome Technologies Market Analysis and Forecasts, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Exosome Technologies Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Exosome Type, 2017 - 2031
    • 11.2.1. Loaded Cargos
      • 11.2.1.1. Peptide
      • 11.2.1.2. siRNA
      • 11.2.1.3. mRNA
      • 11.2.1.4. miRNA
      • 11.2.1.5. Protein
      • 11.2.1.6. Chemical
      • 11.2.1.7. Others
    • 11.2.2. Non-cargo
  • 11.3. Market Value Forecast By Cell Source, 2017 - 2031
    • 11.3.1. HEK293 Cells
    • 11.3.2. MSCs
    • 11.3.3. Platelets
    • 11.3.4. Erythrocytes
    • 11.3.5. Natural Killer Cells
    • 11.3.6. Others
  • 11.4. Market Value Forecast By Application, 2017 - 2031
    • 11.4.1. Therapeutics
      • 11.4.1.1. Oncology
      • 11.4.1.2. Neurodegenerative Diseases
      • 11.4.1.3. Cardiovascular Diseases
      • 11.4.1.4. Infectious Diseases
      • 11.4.1.5. Cosmetics
    • 11.4.2. Diagnostics
  • 11.5. Market Value Forecast By End-user, 2017 - 2031
    • 11.5.1. Health Care Providers
    • 11.5.2. Pharmaceutical & Biotechnology Companies
    • 11.5.3. Others
  • 11.6. Market Value Forecast By Country, 2017 - 2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Exosome Type
    • 11.7.2. By Cell Source
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Exosome Technologies Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Exosome Type, 2017 - 2031
    • 12.2.1. Loaded Cargos
      • 12.2.1.1. Peptide
      • 12.2.1.2. siRNA
      • 12.2.1.3. mRNA
      • 12.2.1.4. miRNA
      • 12.2.1.5. Protein
      • 12.2.1.6. Chemical
      • 12.2.1.7. Others
    • 12.2.2. Non-cargo
  • 12.3. Market Value Forecast By Cell Source, 2017 - 2031
    • 12.3.1. HEK293 Cells
    • 12.3.2. MSCs
    • 12.3.3. Platelets
    • 12.3.4. Erythrocytes
    • 12.3.5. Natural Killer Cells
    • 12.3.6. Others
  • 12.4. Market Value Forecast By Application, 2017 - 2031
    • 12.4.1. Therapeutics
      • 12.4.1.1. Oncology
      • 12.4.1.2. Neurodegenerative Diseases
      • 12.4.1.3. Cardiovascular Diseases
      • 12.4.1.4. Infectious Diseases
      • 12.4.1.5. Cosmetics
    • 12.4.2. Diagnostics
  • 12.5. Market Value Forecast By End-user, 2017 - 2031
    • 12.5.1. Health Care Providers
    • 12.5.2. Pharmaceutical & Biotechnology Companies
    • 12.5.3. Others
  • 12.6. Market Value Forecast By Country, 2017 - 2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Exosome Type
    • 12.7.2. By Cell Source
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country

13. Asia Pacific Exosome Technologies Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Exosome Type, 2017 - 2031
    • 13.2.1. Loaded Cargos
      • 13.2.1.1. Peptide
      • 13.2.1.2. siRNA
      • 13.2.1.3. mRNA
      • 13.2.1.4. miRNA
      • 13.2.1.5. Protein
      • 13.2.1.6. Chemical
      • 13.2.1.7. Others
    • 13.2.2. Non-cargo
  • 13.3. Market Value Forecast By Cell Source, 2017 - 2031
    • 13.3.1. HEK293 Cells
    • 13.3.2. MSCs
    • 13.3.3. Platelets
    • 13.3.4. Erythrocytes
    • 13.3.5. Natural Killer Cells
    • 13.3.6. Others
  • 13.4. Market Value Forecast By Application, 2017 - 2031
    • 13.4.1. Therapeutics
      • 13.4.1.1. Oncology
      • 13.4.1.2. Neurodegenerative Diseases
      • 13.4.1.3. Cardiovascular Diseases
      • 13.4.1.4. Infectious Diseases
      • 13.4.1.5. Cosmetics
    • 13.4.2. Diagnostics
  • 13.5. Market Value Forecast By End-user, 2017 - 2031
    • 13.5.1. Health Care Providers
    • 13.5.2. Pharmaceutical & Biotechnology Companies
    • 13.5.3. Others
  • 13.6. Market Value Forecast By Country, 2017 - 2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Exosome Type
    • 13.7.2. By Cell Source
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country

14. Latin America Exosome Technologies Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Exosome Type, 2017 - 2031
    • 14.2.1. Loaded Cargos
      • 14.2.1.1. Peptide
      • 14.2.1.2. siRNA
      • 14.2.1.3. mRNA
      • 14.2.1.4. miRNA
      • 14.2.1.5. Protein
      • 14.2.1.6. Chemical
      • 14.2.1.7. Others
    • 14.2.2. Non-cargo
  • 14.3. Market Value Forecast By Cell Source, 2017 - 2031
    • 14.3.1. HEK293 Cells
    • 14.3.2. MSCs
    • 14.3.3. Platelets
    • 14.3.4. Erythrocytes
    • 14.3.5. Natural Killer Cells
    • 14.3.6. Others
  • 14.4. Market Value Forecast By Application, 2017 - 2031
    • 14.4.1. Therapeutics
      • 14.4.1.1. Oncology
      • 14.4.1.2. Neurodegenerative Diseases
      • 14.4.1.3. Cardiovascular Diseases
      • 14.4.1.4. Infectious Diseases
      • 14.4.1.5. Cosmetics
    • 14.4.2. Diagnostics
  • 14.5. Market Value Forecast By End-user, 2017 - 2031
    • 14.5.1. Health Care Providers
    • 14.5.2. Pharmaceutical & Biotechnology Companies
    • 14.5.3. Others
  • 14.6. Market Value Forecast By Country, 2017 - 2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Exosome Type
    • 14.7.2. By Cell Source
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country

15. Middle East & Africa Exosome Technologies Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Exosome Type, 2017 - 2031
    • 15.2.1. Loaded Cargos
      • 15.2.1.1. Peptide
      • 15.2.1.2. siRNA
      • 15.2.1.3. mRNA
      • 15.2.1.4. miRNA
      • 15.2.1.5. Protein
      • 15.2.1.6. Chemical
      • 15.2.1.7. Others
    • 15.2.2. Non-cargo
  • 15.3. Market Value Forecast By Cell Source, 2017 - 2031
    • 15.3.1. HEK293 Cells
    • 15.3.2. MSCs
    • 15.3.3. Platelets
    • 15.3.4. Erythrocytes
    • 15.3.5. Natural Killer Cells
    • 15.3.6. Others
  • 15.4. Market Value Forecast By Application, 2017 - 2031
    • 15.4.1. Therapeutics
      • 15.4.1.1. Oncology
      • 15.4.1.2. Neurodegenerative Diseases
      • 15.4.1.3. Cardiovascular Diseases
      • 15.4.1.4. Infectious Diseases
      • 15.4.1.5. Cosmetics
    • 15.4.2. Diagnostics
  • 15.5. Market Value Forecast By End-user, 2017 - 2031
    • 15.5.1. Health Care Providers
    • 15.5.2. Pharmaceutical & Biotechnology Companies
    • 15.5.3. Others
  • 15.6. Market Value Forecast By Country, 2017 - 2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Exosome Type
    • 15.7.2. By Cell Source
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2021)
  • 16.3. Company Profiles
    • 16.3.1. AEGLE Therapeutics
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Test Type Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Aruna Bio, Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Test Type Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Bio-Techne Corporation (Exosome Diagnostics, Inc.)
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Test Type Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Carmine Therapeutics, Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Test Type Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Codiak BioSciences, Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Test Type Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Creative Biolabs
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Test Type Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Danaher Corporation (Beckman Coulter, Inc.)
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Test Type Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Fujifilm Holdings Corporation
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Test Type Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. NOVADIP Biosciences S.A.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Test Type Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. OmniSpirant Limited
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Test Type Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Thermo Fisher Scientific, Inc.
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Test Type Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview

List of Tables

  • Table 01: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031
  • Table 02: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031
  • Table 03: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031
  • Table 04: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 05: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031
  • Table 06: Global Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 07: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 08: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 09: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031
  • Table 10: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031
  • Table 11: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031
  • Table 12: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 13: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031
  • Table 14: North America Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031
  • Table 17: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031
  • Table 18: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031
  • Table 19: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031
  • Table 21: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 22: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 23: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031
  • Table 24: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031
  • Table 25: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031
  • Table 26: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 27: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031
  • Table 28: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 29: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 30: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031
  • Table 31: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031
  • Table 32: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031
  • Table 33: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 34: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031
  • Table 35: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 36: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 37: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031
  • Table 38: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031
  • Table 39: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031
  • Table 40: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 41: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031
  • Table 42: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031
  • Figure 03: Global Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031
  • Figure 04: Global Exosome Technologies Market (US$ Mn), by Loaded Cargos, 2017-2031
  • Figure 05: Global Exosome Technologies Market (US$ Mn), by Non-cargo, 2017-2031
  • Figure 06: Global Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031
  • Figure 07: Global Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031
  • Figure 08: Global Exosome Technologies Market (US$ Mn), by HEK293 Cells, 2017-2031
  • Figure 09 Global Exosome Technologies Market (US$ Mn), by MSCs, 2017-2031
  • Figure 10: Global Exosome Technologies Market (US$ Mn), by Platelets, 2017-2031
  • Figure 11: Global Exosome Technologies Market (US$ Mn), by Erythrocytes, 2017-2031
  • Figure 12: Global Exosome Technologies Market (US$ Mn), by Natural Killer Cells, 2017-2031
  • Figure 13: Global Exosome Technologies Market (US$ Mn), by Others, 2017-2031
  • Figure 14: Global Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 15: Global Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 16: Global Exosome Technologies Market (US$ Mn), by Therapeutics, 2017-2031
  • Figure 17: Global Exosome Technologies Market (US$ Mn), by Diagnostics, 2017-2031
  • Figure 18: Global Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 19: Global Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 20: Global Exosome Technologies Market (US$ Mn), by Health Care Providers, 2017-2031
  • Figure 21: Global Exosome Technologies Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017-2031
  • Figure 22: Global Exosome Technologies Market (US$ Mn), by Others, 2017-2031
  • Figure 23: Global Exosome Technologies Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 24: Global Exosome Technologies Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 25: North America Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 26: North America Exosome Technologies Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 27: North America Exosome Technologies Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031
  • Figure 29: North America Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031
  • Figure 30: North America Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031
  • Figure 31: North America Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031
  • Figure 32: North America Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 33: North America Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 34: North America Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 35: North America Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 36: Europe Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 37: Europe Exosome Technologies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 38: Europe Exosome Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 39: Europe Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031
  • Figure 40: Europe Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031
  • Figure 41: Europe Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031
  • Figure 42: Europe Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031
  • Figure 43: Europe Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 44: Europe Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 45: Europe Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 46: Europe Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 47: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 48: Asia Pacific Exosome Technologies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 49: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 50: Asia Pacific Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031
  • Figure 51: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031
  • Figure 52: Asia Pacific Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031
  • Figure 53: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031
  • Figure 54: Asia Pacific Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 55: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 56: Asia Pacific Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 57: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 58: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 59: Latin America Exosome Technologies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 60: Latin America Exosome Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 61: Latin America Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031
  • Figure 62: Latin America Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031
  • Figure 63: Latin America Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031
  • Figure 64: Latin America Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031
  • Figure 65: Latin America Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 66: Latin America Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 67: Latin America Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 68: Latin America Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 69: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 70: Middle East & Africa Exosome Technologies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 71: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 72: Middle East & Africa Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031
  • Figure 73: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031
  • Figure 74: Middle East & Africa Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031
  • Figure 75: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031
  • Figure 76: Middle East & Africa Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 77: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 78: Middle East & Africa Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 79: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 80: Global Exosome Technologies Market Share Analysis, by Company, 2022